WHITNEY STIREWALT: Open Payments
NPI 1629770862 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 35 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $427 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $137 |
| Novo Nordisk Inc | 5 | $89 |
| Axsome Therapeutics, Inc. | 5 | $78 |
| ABBVIE INC. | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
| Tonix Medicines, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Veozah, CAPLYTA, Auvelity, Kerendia, QULIPTA, FANAPT, Ozempic, TONMYA.
Industry payments across TN — which companies pay providers there.
